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 Drug resistant bacterial infections are an increasing threat to human health across 
the globe. Current treatment options for combating these infections primarily rely on 
antibiotics. Overreliance on the antibiotic therapy continues to accelerate the increase in 
multi-drug resistant infections. Methicillin-Resistant Staphylococcus aureus (MRSA) is 
amongst the most notorious antibiotic resistant bacterial pathogens. Besides MRSA 
infections being difficult to treat, they also lead to complications in patient care resulting 
in extended hospital stays and recurrent visit to the doctors. This imposes a hefty burden 
on the economy. To address this public health challenge, alternative therapeutic strategies 
that mitigate proliferation of antibiotic resistance are crucial. A promising approach that 
is currently pursued as an alternative strategy against bacterial infections is to target 
bacterial pathogenesis. Pathogenesis in Staphylococcus aureus is controlled by a cell 
density-dependent regulatory (quorum sensing) system also known as the accessory gene 
regulator (agr) system. The agr system activates the upregulation of virulence factors that 
allows the bacteria to thrive in a host. Virulence factors refer to the sum of all the 
adaptations and compounds produced by an organism that contributes to how well it 
thrives in a host. Targeting the highly conserved binding sites of the agr system is a 
promising target for broad-spectrum anti-bacterial drugs. One of the compounds that has 
been reported to inhibit the agr system is ambuic acid, a secondary metabolite produced 
by the fungus Pestalotiopsis microspora. Extracts from this fungus exhibit quorum-
quenching activity, but the relationship between compound structure and inhibitory 
 
 
activity of the agr system has not been established. To further the goal of developing an 
innovative countermeasure for MRSA infections that does not drive resistance and can be 
translated into approved therapeutics, the study seeks to identify additional analogs of 
ambuic acid that will provide insight into the relationship between chemical structure and 
quorum sensing inhibitory activity.  
 To accomplish this goal, growth and extraction of Pestalotiopsis microspora 
fungal cultures were optimized in this study. To facilitate expeditious identification of 
known compounds in the extract and prioritize isolation of new novel analogs, 
hyphenated methods combining advanced chromatographic separation techniques, such 
as ultra-high-performance liquid chromatography coupled to high-resolution mass 
spectrometry, have been used. The mass spectrometry data set was subjected to mass 
defect filtering for identification of putative analogs. Nuclear magnetic resonance 
spectroscopy has been used to profile and characterize the structures of ambuic acid, and 
its related analogs isolated from the complex extracts. For evaluation of the inhibitory 
effect of the extracts on the agr system, production of the signaling molecule was 
investigated in a clinically relevant isolate of MRSA (LAC USA 300) cultured with the 
fungal extracts at two concentrations.  
 The outcome of this study has been the identification of putative ambuic acid 
analogs that will provide a starting point for semi-synthetic studies to generate more 
analogs for further studies on the relationship between chemical structures and quorum 
sensing inhibitory activity. These studies will provide the much-needed insight to inform 
 
 
the developments of countermeasure for MRSA infections to augment the use of 
antibiotics.
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CHAPTER I 
INTRODUCTION 
 
 
 Antibiotic resistance - the ability of germs to overcome the drugs formulated to 
kill them- is one the greatest challenges facing global health today.1–3 Even though the 
full global impact of antimicrobial resistance is difficult to quantify, because of the 
exiguity of epidemiological data in many parts of the world, the available data portends 
significant risk to human health.2,3 The U.S. Center for Disease Control and Prevention’s 
2019 Antibiotic Resistance Threats Report (CDC’s 2019 AR Threats Report) underscores 
the continued threat of antibiotic resistance in the Unites States. More than 2.8 million 
antibiotic-resistant infections occur each year, resulting in loss of more than 35,000 lives, 
and encumbering the country with a steep economic burden.1 
 One of the pathogens that has been classified as a serious threat to public health 
and requires a prompt and sustained action is Methicillin-Resistant Staphylococcus 
aureus (MRSA). According to the aforementioned CDC 2019 AR Threats Report, over 
three hundred thousand patients’ hospitalization is attributed to MRSA infection, 
resulting in more than ten thousand deaths and 1.7 billion attributable healthcare costs in 
2017.1 
 Staphylococcus aureus is a gram-positive bacteria that primarily exists as a 
commensal organism and colonizes mucosal membranes and epithelial surfaces of the 
host. 4–8 It is estimated that greater than 30 percent of the healthy adult population is
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colonized with Staphylococcus aureus6. Although S. aureus is more likely to establish its 
presence as a commensal microbe, it has the potential of becoming pathogenic and causes 
many systemic diseases and infections ranging from skin infections to life-threatening 
illnesses. 3,7,9  
 Pathogenesis in Staphylococcus aureus is controlled by a cell density dependent 
regulatory system known as quorum sensing, which results in activation of virulence 
factors. 5–13 Virulence factors refer to the sum of all adaptations and compounds produced 
by an organism that contribute to how well it thrives in a host.4,6,7 These factors consist of 
enzymes, bacterial toxins, cell surface proteins that mediate bacterial attachment, and cell 
surface carbohydrates and proteins that protect the bacterium.6 By employing a 
coordinated and density dependent expression of the genes encoding these virulence 
factors, bacteria can adapt to the environment in the host and improve their chances of 
invading and infecting the host.7  
 While the discovery and development of antibiotics has provided great relief and 
allowed for great advancement in modern medicine, emergence of antibiotic resistant 
pathogens threatens to turn back this advancement. With current treatment options still 
relying on antibiotics, dependence on and overuse of antibiotics continues to accelerate 
the increase in multi-drug resistant (MDR) infections. Methicillin-Resistant 
Staphylococcus aureus (MRSA), are among the first MDR antibiotic resistant bacterial 
pathogen.2,4 While antibiotics still provide much needed treatment for bacterial 
infections, new strategies for augmenting their use is needed. One of the promising 
strategies for combating antibiotic resistance is to target the pathogenesis mechanism of 
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the invading bacteria without exerting selective pressure for development of 
resistance.3,10,13 Suppressing virulence and thus the ability of bacteria to adapt under 
varying environmental conditions represents a novel strategy to attenuate infections 
caused by both gram-negative and gram-positive bacteria.6,10,13,14 
 In S. aureus, the expression of virulence factors, responsible for the invasive 
infection, is mediated by the accessory gene regulator (agr) operon.8,15–17 As outlined in 
Figure 1, the agr-system is known to contain two divergent transcripts, RNAII and 
RNAIII, which are under the control of the P2 and P3 promoters, respectively.6,14,18 The 
P3 transcript is a 517-nucleotide designated as RNAIII and is the effector of the agr-
response. Once expressed, RNAIII initiates the production of a diverse conglomeration of 
virulence factors that promulgates a broad range of physiological activities including 
evading host defenses, adhering to cells and tissue matrix, spreading within the host and 
to degrade cells and tissues , for both nutrition and protection.7,14 The RNAII transcript 
covers a four-gene operon (agrB, D, C, and A), which encodes for the cytosolic, 
transmembrane, and extracellular components of the density-sensing two-component 
signal transduction system. The agrD transcript, AgrD, is a short precursor peptide that 
includes the sequence of the quorum sensing autoinducer, referred to as the autoinducing 
peptide (AIP). 13,17,18 The processing of AgrD into a functional AIP is primarily mediated 
by AgrB.8,13,15,17,19 Upon ArgD binding, AgrB cleaves the C-terminus of AgrD prior to 
catalyzing thioesterification of the C-terminal carboxylate with the thiol moiety of a 
conserved cysteine, which is separated from the C-terminal by four amino acid 
residues.15,17,19 Lastly, the type I signal peptidase SpsB completes the N-terminal 
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cleavage of AgrD, releasing a functional AIP from the cell surface.8,14,18 Secreted AIP 
then binds the receptor histidine kinase, AgrC, on the bacterial surface, resulting in 
phosphorylation and activation of the transcription factor, AgrA. In turn, AgrA binds the 
divergent promoters of the operon, P2 and P3, resulting in continued expression of the 
four protein components of the operon (via P2) as well as expression of RNAIII (via P3). 
 Disruption of the agr-signaling is a promising strategy to combat invasive S. 
aureus infections.3,8,10,12,14,15,19,20 Small molecules that inhibit this system, referred to as 
'quorum quenchers', target the AgrC, AgrA or AgrB. Of these, AgrC has been the subject 
of most research and development, and its extracellular location and function as the AlP 
receptor makes it a prime target for research consideration.10,13,14 However, AgrC has 
shown signs of being prone to mutation and may potentially be a site of future resistance 
developmement.13 By contrast, AgrA and AgrB are highly conserved among the 
Staphylococci and even other gram-positive pathogens.8,13 At present, ambuic acid, a 
novel organic acid present in isolates of the fungal genus Pestalotiopsis , including 
Pestalotiopsis microspora, is the only bona fide inhibitor of agrB, even though its precise 
mechanisms of action or even the binding location has yet to be determined.3,13–15,21,22 
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Figure 1. The agr-System in Staphylococcus aureus. The activity of this system is 
initiated when AIP binds to AgrC, which in turn induces phosphorylation of AgrA, 
activating the P2 and P3 promoters. The P3 promotor regulates the downstream 
production of virulence factors that are associated with the pathogenicity of S. aureus 
infections. Activation of the P2 promoter causes transcription of the genes that encode for 
the components of the agr-system, thereby acting as a positive feedback loop that further 
induces the production of virulence factors. AgrB is responsible for signal biosynthesis, 
cyclization, and secretion of AgrD precursor as AIP. Ambuic acid (biosynthesis inhibitor) 
is the only known agrB inhibitor. Reproduced with permission from Daniel A. Todd, 
Corey P. Parlet, Heidi A. Crosby, Cheryl L. Malone, Kristopher P. Heilmann, Alexander 
R. Horswill, Nadja B. Cech. Copyright 2017 American Society for Microbiology. 
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 Compounds from natural sources, as well as their synthetic derivatives, are highly 
relevant in medicine today comprising over 70 percent of approved anti-infective 
drugs.16,23,24 Approximately one quarter of these natural product derived therapeutics 
were first isolated from fungi.16,24 Recent studies have identified fungal metabolites with 
antivirulence activity against S. aureus, including ambuic acid, a secondary metabolite 
from the endophytic fungi, Pestalotiopsis microspora, an Ascomycetes fungus belonging 
to the order Xylariales.15,21,23,25,26 Some of the published studies have established the 
inhibitory activity of ambuic acid on the quorum sensing signal biosynthetic pathway in 
gram-positive bacteria.13,15,21,22,25,26 For instance, in the in vivo study by Todd et al., a 
single 25 µg prophylactic dose of ambuic acid was shown to almost fully treat skin ulcer 
formation, while a 5-µg dose reduced MRSA-induced abscess formation in a murine 
model by half.13 Additionally, ambuic acid treatment caused significantly less infection-
induced morbidity.3,13,14  
 Ambuic acid is a highly functionalized cyclohexanone which was first isolated 
from endophytes of tropical rainforest plants after several extracts were observed to 
display antivirulence activity against Enterococcus faecalis.15,21,23 Ambuic acid, so named 
in acknowledgment and recognition of the area in Papua New Guinea where the perfect 
stage of P. microspora was first discovered, leading to completion of the description of 
the life cycle of the organism.21 
 With the promising results from these studies, there has been a growing interest in 
identifying additional analogs of ambuic acid with similar, if not better, activity that can 
provide insight into structure activity relationship for this compound. One of the most 
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efficient techniques used to aid the identification and prioritization of isolation of 
analogues is mass defect filtering.27–30 
 Mass defect filtering is a post-acquisition mass spectrometry data filtering 
technique that identifies ions that are within a defined mass defect window around that of 
the compound of interest based on the assumption that compounds with similar chemical 
formulas (and thus similar mass defects) will be structurally similar.30,31,27 The term mass 
defect is defined as the difference between integer mass and the exact mass of the most 
abundant isotope in a molecule. The principle of isotopic abundance, that each element 
contributes to this exact mass and the mass defect, is exploited through definition of a 
filter placed on the full scan mass spectra data to isolate ions that only fall within a user-
defined window around the precursor mass. Mass defect filtering (MDF) of complex MS 
data has been applied for the selective detection of compounds of interest, including 
drugs, their metabolites, endogenous ingredients, and naturally occurring plant 
metabolites.27,28,30,31 
 Inhibition of bacterial pathogenesis is the foundation of the anti-virulence 
approach that is the focus of the studies presented here. Mass defect filtering provides a 
rapid screening tool to direct fractionation or exclude fractions from a complex fungal 
extract by preselecting specific compounds to minimize the number of bioassays that 
must be performed. 
 One of the two main aims in this study is to implement an efficient approach by 
using mass spectrometry data to augment bioassay-directed fractionation in identification 
and isolation of ambuic acid and its related analogs. This will aid the investigations of the 
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relationship between their chemical structure and quorum sensing inhibitory activity. The 
knowledge gained by the described studies supports development of ambuic acid as a 
novel anti-virulence agent against Methicillin-Resistant Staphylococcus aureus. 
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CHAPTER II 
METHODS 
 
 
General Methods 
 All solvents and chemicals used were of reagent, spectroscopic or microbiological  
grade as required and obtained from either Sigma-Aldrich (St. Louis, MO, USA) or 
ThermoFisher Scientific (Waltham, MA, USA). A reference standard of ambuic acid 
(AG-CN2-0129-M001, Adipogen Corp. San Diego, CA) was purchased and used in the 
comparative analysis studies. 
 Flash chromatography separations were accomplished using an automated 
CombiFlash RF system (Teledyne-ISCO, Lincoln, NE, USA) and monitored with a PDA 
detector and an evaporative light scattering detector (ELSD). HPLC separations were 
performed on a Varian HPLC system (Agilent Technologies, Santa Clara, CA, USA) 
with Galaxie Chromatography Workstation software (version 1.9.3.2, Agilent 
Technologies). Analytical HPLC separations employed a Gemini-NX C18 column (5 μm, 
110 Å, 250 × 4.60 mm, while preparative-scale HPLC separations were achieved with a 
250 × 21.20 mm  column; (Phenomenex, Torrance, CA, USA).  
Isolating Ambuic Acid from Cultures of P. microspora  
 To identify and isolate ambuic acid and its structurally related analogs produced 
by the P. microspora, fungal cultures grown on oatmeal solid-state media underwent 
extraction and purification to isolate the secondary metabolites. To permit scaled up 
10 
  
purification of target compounds, separate batch extractions was conducted for a total of 
52 Erlenmeyer flasks (10 g of oatmeal per 250 mL flask). Oatmeal media (Old fashioned 
Quaker oats) was prepared using 10 g of rolled oats in each 250 mL Erlenmeyer flask 
with approximately 17 mL of deionized-H2O, followed by autoclaving at 221 ºC for 30 
minutes using previously outlined methods.32 The batch extractions included a total of 52 
flasks; the total weight of the extracts and number of flasks per batch are as outlined in 
Table 1. 
 Each batch extraction of cultures was achieved by addition of 60 mL of (1:1) 
MeOH-CHCl3 into each 250 mL flask, chopping thoroughly with a spatula, and shaking 
overnight (~16 hours) at ~100 rpm at 22°C. The organic mixture was then filtered on a 
Büchner funnel under vacuum and a mixture of 90 mLCHCl3 and 150 mLH2O (per flask) 
added to the filtrate. Subsequently, the mixture was then stirred for 30 minutes using a 
magnetic stir bar and transferred into a separatory funnel. The organic layer (CHCl3) was 
drawn off and evaporated to dryness in vacuo. The dried organic layer was reconstituted 
in 60 mL of (1:1) MeOH-CH3CN and 60 mL of Hexane per flask, transferred into a 
separatory funnel and shaken vigorously. The defatted organic layer (MeOH-CH3CN) 
was evaporated to dryness in vacuo and the resulting complex extract transferred into 
pre-weighed 20 mL scintillation vial and dried under nitrogen and designated as the 
starting material (SM). 
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Table 1. Crude Extract Masses and Ambuic Acid Yield from P. microspora Batch 
Extractions. Fractions obtained from SM-002, SM-003 and SM-004 were pooled to 
isolate ambuic acid, and the same process was conducted with fractions from SM-005, 
SM-006, and SM-007. 
 
 
 
 An aliquot of three separate biological replicate extracts from P. microspora, SM-
002, SM-003 and SM-004 were combined and designated as G190-18012-54, making a 
total of 2.4 grams. Similarly, extracts SM-005, SM-006 and SM-007 were combined for a 
total of 2.247 g. Each combined batch of extracts was then separately subjected to 
fractionation to isolate ambuic acid. The combined defatted extracts were dissolved in 
minimal volume of CHCl3, absorbed onto Celite 545 (Acros Organics), and fractionated 
by normal phase flash chromatography using a gradient of Hexane-CHCl3-MeOH at a 40 
mL/minute flow rate and 53.0 column volumes ( Figure 5). For the combined material 
from SM-002, SM-003, and SM-004, six fractions were collected and designated as 
Starting 
Material 
Number 
of Flasks 
Resulting 
Extract Mass 
(mg) 
Ambuic Acid 
Yield (mg) 
Ambuic Acid 
Yield (mg)/flask 
G910-18012-9 
(SM- 002) 
6 696.84   
G910-18012-29 
(SM-003) 
6 1278.77 
G910-18012-31 
(SM-004) 
6 807.51 
G910-18012-33 
(SM-005) 
8 960.89   
G910-18012-35 
(SM-006) 
6 657.06 
G910-18012-37 
(SM-007) 
10 1252.83 
29.2 1.22 
49.4 2.74 
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G910-18012-54-I through G910-18012-54-VI (Figure S6). This was repeated for SM-
005, SM-006 and SM-007, and designated as G910-18012-75 (Figure S7). 
 Purification was achieved via preparative HPLC and was conducted from pooled 
fractions 54-IV and 54-V from SM-002, SM-003 and SM-004 using a gradient system 
with starting conditions at 20:80 CH3CN-H2O with 0.1 % formic acid and gradually 
ramped to 100:0 CH3CN-H2O with 0.1 % formic acid over 30 minutes at a flow rate of 
16.9 mL/minutes. Purification was conducted for fractions 54-IV and 54-V with a total 
starting mass of 465.85 mg. As a result, 49.41 mg of ambuic acid were isolated. This 
process was repeated for fractions 75-IV and 75-V from SM-005, SM-006 and SM-007, 
respectively. From this group of fractions, a total mass of 29.17 mg of ambuic acid was 
isolated.  
UHPLC-MS Analysis of the Fungal Extracts 
 To detect ambuic acid and its structurally related analogs from the P. microspora 
cultures, the fungal extracts were dissolved in Optima grade methanol to obtain a final 
concentration of 100 µg·mL-1. Chromatographic separation was performed on an Acquity 
Ultra-Performance Liquid Chromatography (UPLC) system (Waters, Milford, MA) 
equipped with an autosampler kept at 10°C, photodiode array detector (PDA), column 
manager and a binary solvent manager, interfaced to a Thermo LTQ Orbitrap XL mass 
spectrometer with an electrospray ionization (ESI) source. Injections of 3 µL were 
performed on an Acquity UPLC BEH C18 column set at 40°C (1.7 µm, 2.1 x 50mm, 
Waters) with a flow rate of 0.3 mL/min using a binary solvent gradient of water (0.1% 
formic acid added) and acetonitrile (0.1% formic acid added): linear gradient of 15-85 % 
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Acetonitrile over 10 minutes. The negative ionization mode of the mass spectrometer was 
utilized over a full scan of m/z 120-1200 with the following settings: capillary voltage 5 
V, capillary temperature, 300 °C, sheath gas (N2) and auxiliary gas flow rate, 48 and 11 
units respectively. The data dependent MS/MS events were performed on the most 
intense ions detected in full scan MS. The full scans were acquired at a resolution of 
35,000 fwhm while the MS2 scans were acquired at 17,500 fwhm. The MS/MS isolation 
window width was 2 Daltons, and the normalized collision energy (NCE) set to 40 units. 
Each sample was injected in triplicate to provide analytical replicates for analysis.  
 A standard of ambuic acid was analyzed at 50 µg·mL-1 to obtain the characteristic 
retention time. After optimal separation was accomplished, extract samples were 
analyzed, and compounds were identified by matching retention times and exact mass to 
those of the standard on Xcalibur (v. 3.0.63. Thermo Fisher Scientific).  
NMR Spectroscopy 
 For NMR studies, samples were prepared by dissolving the purified extract 
fractions from the crude organic extracts in 450 µL CD3Cl or CD3OD then transferring to 
5 mm 7” NMR tubes. Proton NMR analysis was mostly carried out on a JEOL ECS 400 
MHz spectrometer system equipped with a high sensitivity JEOL Royal probe (NM-
03810R05). Some of the studies were done on a JEOL ECA 500 MHz spectrometer. 
Spectra were processed using MestReNova (Mnova v. 11.0.1-17801, Mestrelab Research 
SL, US) software.
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Quorum Sensing Inhibition Bioassay 
 For this study, a wild type strain of methicillin-resistant Staphylococcus aureus 
(MRSA), USA 300 LAC (AH1263), provided by Dr. Alex Horswill Lab, University of 
Colorado, Anschutz Medical Campus, was used.  
 A single isolated colony inoculum of the MRSA (LAC USA300) strain 
established on Mueller- Hinton broth was grown overnight in Tryptic Soy Broth (Sigma 
Aldrich, St. Louis, MO) at 37°C for 24 hours with shaking at 200 rpm in a New 
Brunswick Scientific shaker/incubator series I-26. Overnight cultures were then diluted to 
1:200 (culture: broth) and shaken at 200 rpm at 37°C for two hours, at which point the 
OD600 was measured to be in the range of 0.08-0.1.  
 A 96 well tissue culture treated flat bottom plate (Corning Incorporated) was 
inoculated with 245 µL of this diluted bacterial inoculum and 5 µL of inhibitor or control 
in each well. Ambuic acid (Adipogen life Sciences), was used as an inhibitor, and was 
prepared at two concentrations, 10 µg·mL-1 and 100 µg·mL-1, respectively. Stock 
solutions of ambuic acid and various fractions were prepared in DMSO and assay content 
of DMSO was 2% in all wells. Assays were performed in triplicate for each treatment and 
control. The vehicle control consisted of 2% DMSO. The plate was incubated at 37 °C 
and shaken at 1000 rpm in a Stuart Microtitre Shaker Incubator (SI505). OD600 was 
measured at 1 hr. intervals using a Synergy H1 Plate Reader and the experiment was 
considered complete at OD600 of 2.0 (~4-6 hrs.). At completion of the incubation time, 
the culture broth containing bacteria was transferred to a clear sterile 96-well, 0.22 µm 
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hydrophilic plate, with low protein binding durapore membrane (MultiScreen®) and 
filtered under vacuum.  The spent media were then analyzed by UPLC-MS.  
UHPLC-MS Analysis of the Bacterial Spent Medium 
 An Acquity UPLC system (Waters, Corporation, Milford, MA) coupled to an 
LTQ-Orbitrap XL hybrid mass spectrometer (Thermo Fisher Scientific, Waltham, MA) 
was used for UHPLC-MS analyses. For the samples collected in the 5 hr. growth 
analysis, a 3 µL injection of each sample was eluted from the column (Acquity UPLC 
BEH C18 1.7 um, 2.1 x 50 mm, Waters Corporation) at a flow rate of 0.3 mL/min with 
solvent A consisting of water (Optima LC-MS grade) with 0.1% formic acid added and 
solvent B consisting of methanol (Optima LC-MS grade). The gradient was initiated with 
an isocratic composition of 80:20 (A:B) for 0.5 min, increasing linearly from 0.5 min to 
6.00 min  to 20:80 (A:B) followed by an isocratic hold for 0.1 min. From 6.10-7.10 min 
the gradient increased linearly to 0:100 with a 0.5 min isocratic hold. The gradient 
returned to initial starting conditions from 7.50-8.00 min and was held for 0.5 min. The 
mass spectrometer was operated in positive ionization mode for the scan range of 150-
1500 with the following settings: capillary voltage of 44V, capillary temperature of 350 
°C, tube lens offset of 50 V, spray voltage of 3.80 kV, sheath gas flow at 35 units, and 
auxiliary gas at 30 units. 
Mass Defect Filtering 
 Identification of ambuic acid analogs was achieved through processing of the 
collected accurate mass spectra of the fractionated extracts from the high-resolution mass 
spectrometers on the Thermo Scientific Compound Discoverer software 2.1.0.398. 
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 The negative ion mode LC-MS data acquired from the Q Exactive Plus were 
analyzed, aligned, and filtered with the MS1 detected ions subjected to formula prediction 
using the following parameters from the workflow nodes: lower RT limit 3, upper RT 
limit 7, minimum precursor ion mass of 100 Da and maximum, 5000 Da. The maximum 
tolerance of mass error set at 5 ppm: H-C ratio was below 5; RDBE (degree of 
unsaturation) was defined at max of 40, noise level at 1.0 × 103 counts, mass tolerance of 
500 Da and mass defect tolerance of 50 mDa for the specified elemental composition of 
C19H26O6.  
17 
  
CHAPTER III 
RESULTS AND DISCUSSION 
 
 
Ambuic Acid Production by Pestalotiopsis microspora 
 Species within the fungal genus Pestalotiopsis have attracted research as a 
commonly isolated endophyte of tropical plants which has been shown to produce a 
variety of bioactive and structurally complex secondary metabolites.21,23,33–35 One of the 
most common Pestalotiopsis species is P. microspora.21,23,33,34 
 To assess production of ambuic acid and other secondary metabolites in cultures 
of P. microspora, the LC-MS data obtained from the extract were analyzed using the 
Xcalibur software to create base peak and selected ion chromatograms. The average 
molecular mass of ambuic acid is 350.4130, calculated from its elemental composition of 
C19H26O6. The theoretical monoisotopic mass, computed by taking the sum of the 
accurate masses of the most abundant or primary isotope of each atom in the 
molecule28,36, for ambuic acid is 350.1729. A comparative analysis of the UHPLC-MS 
data acquired in the negative ion mode yielded evidence of presence of ambuic acid in 
the extracts. Identification of ambuic acid in the complex extract was achieved through 
detection of the deprotonated molecular ion [M-H]-1. Ambuic acid’s deprotonated 
molecular ion has an m/z value of 349.1651, eluting at a retention time of 4.59 minutes. 
The m/z value represents the mass to charge ratio, which is dimensionless because it 
describes the ratio between the molecular ion mass number (m) and the number of 
18 
  
elementary charges (z).36–38 For the deprotonated molecular ion of ambuic acid [M-H]-1, 
the m/z value is arrived at by subtraction of hydrogen’s mass number from the 
monoisotopic mass of ambuic acid, as shown in Table 2.  
 
Table 2. Calculating Ambuic Acid’s Deprotonated Molecular Ion  
 
 
 
 Qualitatively, ambuic acid was confirmed to be present in the extracts by 
comparison of accurate mass and retention time to that of a standard of ambuic acid. The 
selected ion chromatograms of two extracts of biological replicates (separate cultures) of 
P. microspora, SM-01 and SM-02, have similar retention times to that of a standard of 
ambuic acid as illustrated in Figure 2. Ambuic acid was determined to be a major 
component of the complex crude extract and its structure was established after 
chromatographic separation and purification. Confirmation was achieved by comparison 
of the chemical shifts and the coupling constants of the proton NMR data of the isolate 
with the literature reported data21 as conveyed on Table 3.  
Ambuic Acid Monoisotopic mass 350.1729 
Hydrogen Mass number 1.0078 
Deprotonated Ambuic acid m/z value 349.1651 
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Figure 2. Identification of Ambuic Acid in P. microspora Extracts. Selected ion 
chromatograms were constructed for the ambuic acid standard and replicate extracts at an 
m/z value of 349.1651, [M-H]-1, at a retention time of 4.59 minutes, with an isolation 
window of 5ppm and normalized to 3.99 × 105. The chromatogram in (A) represents a 
standard of ambuic acid analyzed at a concentration of 50 µg·mL-1. (B) and (C) were 
obtained by analysis of two replicate extracts from separate cultures of P. microspora at 
a concentration of 100 µg·mL-1 and are referred to as SM-01 and SM-02. SM-
Abbreviation for starting material, representing the two separate extractions of biological 
replicates of the P. microspora. 
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Table 3. Tabulated Comparative List of the Proton (
1
H) Assignments. The isolated 
fraction’s 
1
H NMR data was processed using MestReNova software (v. 11.0.1-17801). 
All reported data were obtained in d
4
-methanol (CD
3
OD). Ambuic acid isolated from P. 
microspora via preparative HPLC. 
 
 
Values for ambuic acid from literature 
Experimentally measured 
values for ambuic acid 
from P. microspora  
Carbon 
# 
δ 13C δ1H Coupling δ1H Coupling 
1 171.2     
2 131.9     
3 136.6 6.67 t, J = 7.5 6.68 t, J = 7.3 
4 28.8 2.78 q of d, J = 7.8,15.8 2.81 q of d, J = 7.8, 15.8 
5 61.3     
6 61.1 3.74 d, J = 2.8 3.74 d, J = 2.8 
7 66.0 4.81 s 4.81 S 
8 150.7     
9 132.0     
10 196.0     
11 122.8 6.13 d, J = 15.9 6.12 d, J = 15.9 
12 140.3 5.83 m 5.82 m 
13 34.6 2.15 q, J = 7.0 2.14 q, J = 7.1 
14 30.0 1.43 m 1.43 m 
15 32.6 1.32 m 1.31 m 
16 23.6 1.32 m 1.31 m 
17 14.5 0.90 t, J = 6.9 0.89 t, J = 6.9 
18 13.0 1.86 s 1.85 s 
19 60.3 4.39 d, J = 12.9 4.39 d, J = 12.9 
 4.51 d, J = 12.9 4.50 d, J = 12.9 
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AIP-I Inhibition Assay 
 In order to examine if the inhibitory activity of ambuic acid and analogs resulted in the 
inhibition of the agr quorum sensing system, production of the signaling molecule, auto-inducing 
peptide-I (AIP-I), was investigated in clinically relevant isolate of MRSA (LAC USA300). The 
complex extracts (SM-01 and SM-02) representing the starting material, were cultured with 
bacterial cells and ambuic acid standard at two concentrations, 10 µg·mL-1 and 100 µg·mL -1. 
Ambuic acid is hypothesized to inhibit the production of AIP-I through inhibition of AgrB and 
generally have no antimicrobial growth effect at concentrations below 200 µg·mL-1 39. Since AIP 
production is dependent on cell density, a growth curve was created by tracking cell growth. 
Growth of cells was measured by turbidity using optical density hourly, for four hours (Figure 3). 
The data suggests that ambuic acid does not inhibit growth of bacteria both at 10 µg·mL-1 and at 
100 µg·mL-1. However, the bacterial cells cultured with the extracts (SM-01 and SM-02) at 
100µg·mL-1 exhibited a suppressive growth effect on MRSA. These are complex extracts and it is 
likely that some of the constituents in the extracts are responsible for the suppressed growth at 
100 µg·mL-1. With further fractionation and purification, the constituents responsible for the 
quorum sensing inhibitory activity were separated from the antimicrobial components. 
 Evaluation of the inhibitory activity of the extracts on the agr system was 
monitored through production of the macrocyclic peptide, AIP-I. This was achieved 
through qualitative measurement of AIP in the culture filtrate by LC-MS analysis. The 
quorum sensing cyclic peptide of MRSA, AIP-I, was clearly detected by LC-MS analysis 
of the culture filtrate. A comparative analysis of the peak area corresponding to AIP-I 
qualitatively showed a decrease in the peak areas at the two concentrations, 10µg·mL and 
100µg·mL, when this strain was cultured with SM-01 and SM-02 as compared to ambuic 
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acid standard at the same concentration, Figure 4. Both at 10 µg·mL-1 and at 100µg·mL-
1, SM-01 and SM-02 exhibit a comparatively similar AIP-I inhibition as the ambuic acid 
standard. However, the observed activity is not attributable to ambuic acid alone since 
both SM-01 and SM-02 exhibited growth inhibition at 100 µg·mL-1. Collectively, the 
data presented in Figures 2-4 demonstrated that the P. microspora extracts contained 
ambuic acid and further suggested that the ambuic acid therein possess quorum sensing 
inhibition activity. The results for the quorum sensing inhibition assay are somewhat 
confounded by antimicrobial effects, therefore, it was necessary to carry out further 
fractionation to separate the putative quorum sensing inhibitors from the antimicrobial 
constituents in the extracts.  
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Figure 3. MRSA Growth Curves. The growth curves for MRSA USA300 LAC 
(AH1263) were constructed from turbidimetric measurements at OD600. The 
vehicle consisted of 2% DMSO in tryptic soy broth while ambuic acid standard 
served as the positive control. Triplicate wells were prepared for the controls and 
SM-01 and SM-02 and incubated for 4 hours at 37˚C and OD600 measurement 
were collected hourly. (A) and (B) were obtained by plotting absorbance 
measurements at 10 µg·mL-1 and 100 µg·mL-1, respectively. Background 
absorbance was subtracted using wells containing samples without bacteria. 
Error bars are representative of the standard error of the mean of the triplicates. 
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Figure 4. AIP-I Percent Inhibition in MRSA. Normalized AIP-I percent inhibition 
in MRSA by ambuic acid and extracts from P. microspora. Peak areas were 
calculated using Xcalibur software version 3.0.63 and the data exported to Excel for 
calculation of mean peak areas. AIP-I inhibition was calculated by normalizing to 
vehicle (2% DMSO). Error bars are representative of the standard error of the mean. 
of the triplicates. 
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 Consequently, three separate biological replicate extracts from P. microspora, 
were combined, designated G910-18012-54, and subjected to flash chromatography. 
Each batch extract was designated as the starting material and referred to as SM as 
outlined in the method section. An aliquot of biological replicate extracts SM 002, SM-
003 and SM-004 were combined, making a total of 2.4 grams. This was then fractionated 
and analyzed following the work flowchart depicted in Figure 5. A total of six fractions 
were collected by pooling of the eluates collected under the same peak with 95% 
recovery, Figure S6. Fractions eluting with 80% chloroform/hexanes and 100% methanol 
were expected to contain ambuic acid and the analogs. Examination of plotted selected 
ion chromatograms positively confirmed presence of ambuic acid in the fourth (54-IV) 
and fifth (54-V) factions. Further isolation of the two fractions (54-IV and 54-V) via 
preparative HPLC yielded 49.41 milligrams of pure ambuic acid with positive 
confirmation of the structure achieved through comparison of the observed nuclear 
magnetic resonance chemical shifts to published data21 as conveyed on Table 3 and in 
Figures S2 and S3. The process was repeated for three other combined replicate extracts, 
SM 005-007 with a total of 29.17 milligrams of pure ambuic acid isolated. Thus far, a 
total of 78.58 of pure ambuic acid has been isolated from seven separate batch extractions 
of cultures of P microspora. 
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Figure 5. Fractionation Workflow Chart. Three biological replicate extracts of P. 
microspora labelled SM-002, SM-003 and SM-004, were combined and designated 
G910-18012-54. ISCO flash chromatography of the combined replicates yielded six 
fractions, 54-I through 54-VI. Fractions were analyzed by high resolution mass 
spectrometry and the resulting data set subjected to mass defect filtering. Fraction 54-
III yielded an analog of ambuic acid with predicted formula of C18H32O3 while 
Fraction 54-IV yielded ambuic acid, molecular formula C19H26O6 
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Identification of Analogs Through Mass Defect Filtering 
 Based on the hypothesis that the MRSA quorum sensing inhibitory activity of 
extracts from the fungus Pestalotiopsis microspora is due to the effects of ambuic acid 
and its analogs on the agr signal transduction system that is responsible for pathogenesis 
and virulence in the bacteria, Compound Discoverer, a qualitative post acquisition data-
processing application that uses accurate mass data, isotope pattern matching, and mass 
spectral library searches, was employed for the structural identification of putative 
ambuic acid analogs.30,38 To rigorously characterize these new compounds, the fractions 
collected from flash chromatography were subjected to mass defect filtering and analyzed 
for analogs identification. The LC-MS data were subjected to mass defect filtering with a 
signal threshold set at 1.0 × 103 and mass tolerance and mass defect tolerance set at ±500 
Da and 0.05, respectively. A total of 1175 compounds were identified as having matching 
patterns indicating all required isotopes of searched pattern were found. Out of these, 
1026 were identified as having the predicted compositions as C19H26O6, indicating a 
match between the assigned annotation and the available results. A compound with the 
molecular formula established as C18H32O3 on the basis of its HRESIMS (m/z 295.2287, 
[M-H]-1) was identified as the most abundant analog of ambuic acid in the P. microspora 
extracts, falling within a 0.0622 mass defect of ambuic acid, with a nominal mass 
difference of 54 Da, as outlined in Table 4. This putative analog was determined to be in 
the second (54-II) and third (54-III) fractions of the combined SM-02 to SM-04 
biological replicates of P. microspora extracts, Figure 6.
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Table 4. Putative Analog Identification. Based on the structure of ambuic acid 
(C19H26O6), a mass defect filter was defined with the mass tolerance of C19H26O6 ± 500 
Da and mass defect tolerance of ± 50 mDa.  Mass defect calculated as the difference 
between the integer mass and the monoisotopic mass of the most abundant isotopes in a 
molecule. 
 
 
 
 Formula 
Prediction 
MW 
(accuracy 
in ppm) 
RTa 
(Min) 
m/z 
Monoisotopic 
mass [ M-H]-1 
Nominal 
mass  
[ M-H]-1 
Mass 
defect 
Ambuic 
Acid 
C19H26O6 350.17382 4.590 349.1651 349 0.1651 
Putative 
Analog 
C18H32O3 296.23595 6.080 295.2273 295 0.2273 
Difference 1 C, 6 H, 3 O 53.93787 1.49 53.9378 54 0.0622 
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Figure 6. Chromatograms Showing Ambuic Acid and a Putative Analog. Base peak 
chromatograms from the UPLC -MS analysis of the fractions from the combined SM 02-
SM-04, highlighting the retention times of ambuic acid’s deprotonated molecular ion 
with a formate adduct [M+FA-H]-1 at 4.58 min and m/z value of 395.1719 and the 
putative analog’s deprotonated molecular ion [M-H]- at retention time range of 5.88-6.10 
min and m/z value 295.2287 plotted with an isolation window of 5 ppm and normalized 
to 7.68 × 108 . The first chromatogram represents a standard ambuic acid analyzed at a 
concentration of 50 µg·mL-1. Fractions 54-I through 54-VI were obtained by analysis of 
the ISCO fractions from fractionation of SM 02-SM-04, from cultures of P. microspora 
analyzed at a concentration of 100 µg·mL-1 
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 Further studies to examine the effect of the putative analog containing fraction on 
the agr quorum sensing system were carried out by investigation of production of the 
signaling molecule, auto-inducing peptide-I (AIP-I), in clinically relevant isolate of 
MRSA (LAC USA300) as previously outlined. The results of the study suggest that the 
analog has inhibitory effect on the AIP-I production without effect on the growth of the 
bacteria both at 10 µg·mL-1 and at 100 µg·mL-1. Fraction 54-III, the fraction in which the 
putative analog was identified, shows no growth inhibitory effects at the two 
concentrations used in the study, Figure 7. Analysis of the peak area of AIP-I similarly 
depicts a reduction in the AIP-I production as compared to the 2% DMSO vehicle 
control, thus, inferring that the constituents in both fraction 54-II and 54-III inhibit the 
AIP-I production, Figure 8. As a putative analog of ambuic acid, isolated compound with 
the predicted formula C18H32O3 will provide additional information for the structure 
activity relationship studies in relation to quorum quenching activity in MRSA and 
development and optimization of ambuic acid as an antivirulence agent. Structure 
elucidation for the compound is ongoing.  
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Figure 7. MRSA Growth Curves for Fraction 54-I to 54-VI. The growth curves were 
established from turbidimetric measurements at OD600. The vehicle control consisted of 
2% DMSO in broth while ambuic acid standard served as positive control. Triplicate 
wells were prepared for the controls as well as the fractions and incubated for 4 hours at 
37˚C. (A) and (B) were obtained by plotting absorbance measurements at 10 µg·mL-1 
and 100 µg·mL-1 respectively. Background absorbance was subtracted using wells 
containing samples without bacteria and errors bars are representative of the standard 
error of the mean of the triplicates. 
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Figure 8. Bioactivity of Fractions 54-I to 54-VI. Fractions collected from fractionation 
of the combined replicate complex extracts (starting materials, SM-02-SM-04) and 
designated SM-18012-54, were tested for AIP biosynthesis inhibition. Ambuic was used 
as a positive control for comparative analysis of biological response. SM-18012-54 (the 
starting material) was tested for comparison. Error bars are representative of the standard 
error of the mean of the triplicates. 
33 
  
CHAPTER IV 
CONCLUSION 
 
 
 One of the novel strategies aimed at attenuating progression of infections caused 
by bacteria is by suppressing their ability to adapt under varying environmental 
conditions.14,18,39,40 Research efforts aimed at the discovery and development of small 
molecule agr system inhibitors have yielded some promising leads.14–16,39 Small molecule 
inhibitors targeting the most conserved AgrB may be one of the best candidates for 
therapeutic development and every lead needs to be pursued. 
 The studies presented here have outlined an optimized method for extraction, 
purification, and identification of ambuic acid and its related structural analogs from solid 
media cultures of the fungus Pestalotiopsis microspora. A total of 80 milligrams of 
purified ambuic acid was isolated from 52, 10-gram flasks, in seven different batches of 
growths. Access to this material will enable further investigations of mechanism of action 
for this molecule and will provide a starting point for semi-synthetic studies to generate 
more analogs for structure activity relationship studies.  
 Recently, mass defect filtering, a technique for detecting both common and 
unique metabolites, has been utilized for detection of compounds of interest. 
Traditionally, natural products discovery depended on exhaustive and challenging 
bioassay-guided fractionation and purification of active constituents, followed by their 
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identification based on nuclear magnetic resonance (NMR) and mass spectrometry (MS) 
data. Integrating these technologies in our studies offered a powerful tool capable of 
identifying putative active compounds in the complex extracts as well as simplifying the 
process, thus saving costs and time. By combining these technologies, we optimized the 
isolation protocols for ambuic acid analogs. Mass defect filtering has broad applications 
to natural products chemistry and will be useful in other natural products discovery 
programs. This approach accelerated processing of ion mass information and allowed 
grouping of compounds based on the narrow mass defect, even when their nominal mass 
difference was significant. Consistent with other recently published studies28,36,37, it was 
found that coupling mass defect filtering with bioassay-directed fractionation offered a 
complementary process to traditional bioactive compound discovery, focusing on 
targeted compounds and requiring fewer processing steps as compared to the traditional 
cycle of fractionation, bioassay, and characterization. 
 Multidrug resistant pathogens, like MRSA, pose a significant challenge for the 
currently available clinical care. Therefore, modified use of the available antimicrobial 
agents and public health interventions, coupled with novel antivirulence strategies, may 
help in mitigating the effects of the multidrug-resistant organisms in the future.  
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Figure S1. Molecular Structure of Ambuic Acid.  
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Figure S2. 1H NMR Spectrum of Ambuic Acid Isolated from P. microspora. 1H NMR (68-II, 500 MHz; CD3OD) 
Spectrum of ambuic acid isolated from cultures of P. microspora via preparative HPLC. G910- represents the fungal isolate 
code, while 18012-68, represents the notebook number and page. II is the fraction ID. 
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Figure S3. 13C NMR Spectrum of Ambuic Acid Isolated from P. microspora. 13C NMR Spectrum (125 MHz; CD3OD) of 
ambuic acid isolated from P. microspora via preparative HPLC. G910- represents the fungal isolate code, while 18012-57, 
represents the notebook number and page. II is the fraction ID. 
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Figure S4. 1H NMR Spectrum of an Analog Isolated from P. microspora. 1H NMR (140-VIII, 400 MHz; CD3OD) 
Spectrum of ambuic acid isolated from cultures of P. microspora via preparative HPLC. G910- represents the fungal isolate 
code, while 18012-140, represents the notebook number and page. VIII is the fraction ID. 
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Figure S5. Mass Defect Filtering Workflow Chart. A filter for centroid peaks in 
MS1 spectra was set for mass defect ranges calculated from ambuic acid's molecular 
formula composition, C19H26O6, with m/z tolerance set at 500 Da and mass defect 
tolerance of 50 mDa.  Negative polarity base peak chromatograms set to be isolated 
within 5ppm and isotopic pattern created, with detected unknown compounds in the 
data using Component Elucidator Algorithm. All the detected compounds were set to 
be grouped by molecular weight and retention time across all files. 
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Figure S6. G910-18012-54 Recovered Masses. The bar graph represents the recovered 
masses of fractions collected from fractionation of the combined replicate biological 
extracts, SM-002, SM-003 and SM-004. The fractions are identified by the fungal strain 
number-910, notebook number 18012, and page and fraction number 54-I through 54-
VI. Percent recovery was calculated form the formula: % recovery = 
Recovered/Injected × 100. The masses are in milligrams. 
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Figure S7. G910-18012-75 Recovered Masses. The bar graph represents the recovered 
masses of fractions collected from fractionation of the combined replicate biological 
extracts, SM-005, SM-006 and SM-007. The fractions are identified by the fungal strain 
number-910, notebook number 18012, and page and fraction number 75-I through 75-VI. 
Percent recovery was calculated form the formula: % recovery = Recovered/Injected × 
100. The masses are in milligrams. 
